Leptospirosis in Dogs: Clinical Signs, Zoonotic Risk, and Diagnostic Approaches
Introduction
Leptospirosis is a globally distributed zoonotic bacterial disease caused by pathogenic spirochetes of the genus Leptospira. In dogs, infection typically results from exposure to urine-contaminated water, soil, or fomites, with transmission facilitated by contact with mucosal surfaces or abraded skin [3, 6]. The disease exhibits a complex epidemiology shaped by climatic factors, reservoir host dynamics, and serovar distribution [2, 10]. Canine leptospirosis represents a diagnostic challenge because its clinical presentation overlaps with numerous other febrile and hepatorenal conditions, and because acute-phase serological titers are often negative [1, 8]. This article provides a detailed review of the clinical signs, zoonotic implications, and current diagnostic approaches, emphasizing the use of the microscopic agglutination test (MAT) and polymerase chain reaction (PCR) assays. The reference list draws on recent outbreak investigations, seroprevalence studies, and molecular characterizations to support evidence-based practice [3, 9, 13].
Etiology and Serovar Distribution
Pathogenic leptospires are classified into serogroups and serovars based on lipopolysaccharide (LPS) antigenic structure. In dogs, the most frequently implicated serovars globally include Leptospira interrogans serovars Icterohaemorrhagiae, Canicola, and Australis, as well as L. kirschneri serovar Grippotyphosa and L. interrogans serovar Pomona [6, 10]. Regional variation is substantial. For example, a molecular surveillance study in northern Colombia identified a predominance of serogroup Sejroe and Serjani among domesticated dogs [11]. In sub‑tropical Mexico, seroprevalence for pathogenic leptospires in both domiciled and stray dogs exceeded 30%, with serovars Canicola and Icterohaemorrhagiae most common [15]. An outbreak investigation in Los Angeles County, California, revealed serogroups Australis, Autumnalis, and Icterohaemorrhagiae in canine cases, underscoring the need for local epidemiological data [3]. The recognition of novel serovars and the potential for host‑jumping events is aided by genomic comparison of isolates from dogs, humans, and wildlife [10].
Clinical Signs in Dogs
The incubation period ranges from 4 to 12 days. Disease severity varies from subclinical infection to fulminant multi‑organ failure, with young, unvaccinated, and male dogs at higher risk [8]. The classic presentation is acute febrile illness with leptospiremia, followed by localization to the kidneys, liver, lungs, and occasionally the central nervous system.
Acute Kidney Injury
Leptospires colonize the renal tubules, causing interstitial nephritis and tubular necrosis. Clinical signs include polyuria, polydipsia, vomiting, dehydration, and oliguric or anuric renal failure. Serum biochemistry reveals elevated creatinine, blood urea nitrogen, and phosphorus. Urinalysis often shows proteinuria, granular casts, and glucosuria due to proximal tubular damage [1, 8]. In a serial evaluation of ten dogs with leptospirosis, renal functional parameters worsened during the first 48 hours of hospitalization, even with appropriate antimicrobial therapy [1].
Acute Liver Injury
Hepatic involvement presents as icterus, hepatomegaly, and elevated liver enzyme activities (alanine aminotransferase, alkaline phosphatase) and hyperbilirubinemia. Coagulopathies may develop secondary to hepatic synthetic dysfunction and thrombocytopenia [4]. Serum sialic acid concentration has been investigated as a biomarker of inflammation and infection; elevated levels were noted in leptospirosis‑affected dogs and correlated with leukocytosis and acute phase protein responses [4].
Pulmonary Hemorrhage
Pulmonary leptospirosis is increasingly recognized and can be rapidly fatal. Dogs present with dyspnea, tachypnea, cough, and hemoptysis. Thoracic radiography or computed tomography reveals diffuse alveolar infiltrates and interstitial patterns. The pathophysiology involves vasculitis and immune‑mediated damage to pulmonary capillary endothelium, leading to intra‑alveolar hemorrhage. In the serial study by Bringold et al., pulmonary structural changes were documented via CT and persisted beyond the acute phase in some dogs [1].
Other Clinical Manifestations
Gastrointestinal signs (vomiting, diarrhea, hematemesis, melena) are common. Myalgia, stiffness, and reluctance to move are frequently reported by owners. Less common signs include uveitis, meningitis, and myocarditis [1, 9].
Zoonotic Risk and One Health Implications
Canine leptospirosis is a significant public health concern because infected dogs shed leptospires in urine for weeks to months after clinical recovery. Direct contact with urine, contaminated bedding, or water sources carries a high risk of human infection [6, 7]. The zoonotic risk is magnified in households with children, immunocompromised individuals, or pregnant women. The One Health approach integrates human, animal, and environmental surveillance. A scoping review of international evidence found that meteorological factors such as rainfall, temperature, and flooding are strong drivers of canine leptospirosis incidence, and these same factors predict human outbreaks [2]. An epidemiological study in rural Colombian farms used a One Health framework to link leptospiral carriage in bovines to canine and human seroprevalence [5]. Similarly, a serosurvey in a Brazilian indigenous community demonstrated overlapping positivity for leptospirosis among dogs and their owners, reinforcing the need for integrated control measures [7]. The systematic review and meta‑analysis by Wei et al. of human and canine leptospirosis in China identified dog ownership as a risk factor for human infection, particularly in regions where rodent control is inadequate [6].
Veterinarians and veterinary staff are at occupational risk. Personal protective equipment (gloves, goggles, waterproof footwear) and strict hygiene protocols must be enforced when handling suspect cases. Owners should be educated about urine‑borne transmission and the importance of environmental decontamination with disinfectants such as bleach (1:10 dilution) or quaternary ammonium compounds.
Diagnostic Approaches
Diagnosis of canine leptospirosis relies on a combination of clinicopathological findings, serology, molecular detection, and culture. Serum sialic acid has been explored as a non‑specific but adjunctive marker of infection [4]. No single test is perfect; the sensitivity and specificity of each assay depend on the stage of disease, prior vaccination, and serovar diversity.
Serology: Microscopic Agglutination Test (MAT)
MAT remains the reference standard for serodiagnosis. The assay detects agglutinating antibodies (primarily IgM and IgG) against a panel of live leptospire serovars. A four‑fold rise in titer between acute and convalescent samples (collected 2–4 weeks apart) is considered confirmatory. A single titer of ≥1:800 in a clinically compatible case is highly suggestive [3, 13]. MAT sensitivity declines during the chronic carrier phase and can be low in acute leptospiremia because antibodies may not be detectable for 5–10 days post‑infection. Additionally, prior vaccination can yield false‑positive titers, usually of lower magnitude (≤1:400) unless recent booster has occurred. Cross‑reactions among serogroups complicate interpretation.
Recombinant Antigen‑Based Assays
To overcome the limitations of live‑antigen MAT, recombinant protein assays have been developed. A lateral flow assay (LFA) utilizing gold‑nanoparticle‑conjugated Loa22, a conserved leptospiral outer membrane protein, showed promising sensitivity and specificity in preliminary canine and bovine evaluations [12]. Such rapid, point‑of‑care tests could facilitate field diagnosis where laboratory infrastructure is limited.
Molecular Diagnostics: PCR
Real‑time PCR targeting the lipl32 gene (specific for pathogenic Leptospira) or the 16S rRNA gene provides high analytical sensitivity and can detect leptospiral DNA in blood, urine, or tissues before seroconversion occurs [9, 11]. Blood PCR is most sensitive during the first week of illness (leptospiremic phase), while urine PCR becomes positive after the second week and can remain positive for weeks [8, 9]. In a study of canine leptospirosis in Thailand, pathogenic Leptospira were identified by PCR in both urine and blood samples from dogs undergoing neutering, indicating subclinical shedding [9]. Molecular typing (e.g., secY sequencing) can identify the infecting serovar at the genotype level, which is invaluable for epidemiological surveillance and vaccine matching [10, 11].
Urine PCR is affected by pH and bacterial load; sample storage and DNA extraction efficiency must be optimized. In general, PCR is now recommended as a first‑line diagnostic tool in acutely ill dogs, particularly because it does not depend on antibody responses and can provide results within hours.
Culture and Isolation
Bacteriological culture using Ellinghausen‑McCullough‑Johnson‑Harris (EMJH) medium is definitive but slow (weeks) and insensitive (≤50% in clinical samples). It is rarely used for routine diagnosis but remains important for research and vaccine strain selection.
Imaging and Clinical Pathology
Abdominal ultrasound reveals renomegaly, increased cortical echogenicity, and pyelectasia. Thoracic radiographs or CT identify pulmonary infiltrates [1]. Clinicopathological markers include leukocytosis, left shift, thrombocytopenia, azotemia, hyperbilirubinemia, elevated liver enzymes, and electrolyte disturbances (hyponatremia, hypokalemia). Novel biomarkers such as serum sialic acid may help differentiate inflammatory from non‑inflammatory renal disease [4].
Diagnostic Decision Tree
The following Mermaid diagram outlines a suggested diagnostic workflow for a dog presenting with acute febrile illness and evidence of renal or hepatic injury.
flowchart TD
A[Acute febrile dog <br/> with polyuria/polydipsia, <br/> vomiting, icterus, or dyspnea], > B{Check baseline: <br/> CBC, chemistry, UA, <br/> thoracic radiographs}
B, >|Azotemia, bilirubinemia, <br/> thrombocytopenia| C[Clinical suspicion: <br/> Leptospirosis]
B, >|Normal or alternative <br/> pattern| D[Consider other <br/> differentials <br/> (e.g., canine parvovirus, <br/> bacterial sepsis, <br/> hepatotoxins)]
C, > E{Acute vs. convalescent <br/> timing?}
E, >|< 7 days illness| F[Blood PCR + MAT acute]
E, >|> 7 days illness| G[Urine PCR + MAT acute]
F, > H[PCR positive?]
G, > H
H, >|Yes| I[Confirm diagnosis. <br/> Start Doxycycline + <br/> supportive care. <br/> Repeat MAT in 2-4 weeks.]
H, >|No| J{MAT titer ≥ 1:800 <br/> or 4-fold rise?}
J, >|Yes| I
J, >|No, single low titer| K[Consider repeat MAT <br/> in 2 weeks. <br/> Perform urine PCR. <br/> Consider other causes.]
I, > L[Report to public health. <br/> Advise owner on <br/> zoonosis prevention. <br/> Isolate dog from <br/> other pets and family.]
L, > M[Monitor renal function, <br/> liver enzymes, <br/> respiratory status. <br/> Serial CT if pulmonary <br/> signs present.]
Management and Public Health Response
Once a diagnosis is established, the dog should be isolated from other animals and from immunocompromised household members. Antimicrobial therapy with doxycycline (5 mg/kg twice daily for 14 days) is first‑line for eliminating the carrier state; penicillin‑based drugs (e.g., ampicillin) are used for acute leptospiremia but do not clear renal carriership. Fluid therapy, antiemetics, and renal replacement therapy (hemodialysis, peritoneal dialysis) may be required for acute kidney injury.
Vaccination against the most prevalent serovars reduces disease severity and shedding but does not provide sterilizing immunity. Owners should be counseled on vaccination protocols and environmental hygiene [6, 8].
Conclusion
Canine leptospirosis remains a diagnostic challenge due to its non‑specific presentation and the temporal limitations of serology. A combined approach using acute‑phase blood PCR, paired MAT, and urine PCR after the first week provides the highest diagnostic accuracy. The disease carries a significant zoonotic risk, and a One Health framework that integrates meteorological forecasting, reservoir control, and public education is essential for reducing incidence. Emerging tools such as recombinant‑antigen lateral flow assays and genomic surveillance promise to improve diagnosis and epidemiological understanding [10, 12].
References
Bringold C, Schweighauser A, Walther S, et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42224492/
Hobson SJ, Zai B, Vyn CM, et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211529/
Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/
Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148179/
Patiño‑Gómez S, Naranjo‑Vargas LF, Aguirre‑Acevedo DC, et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42090421/
Wei W, Jiao D, Dong X, et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta‑analysis. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864068/
Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni‑ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/
Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41814781/
Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W, et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637464/
Kakita T, Takabe K, Morita M, et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41579465/
Beltrán‑Sánchez CA, Bettin AC, Castellanos‑Romero K, et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557245/
Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22‑gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/
Ding Y, Zhang S, Zhang W, et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41383393/
Jost HE, Henriksen ML, Hawley J, et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: a pilot study. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41378760/
Andrade‑Silveira E, Segura‑Correa JC, Ortega‑Pacheco A, et al. Seroprevalence of pathogenic leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359150/